ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 290

Children With JIA Show Distinct Patterns Of Improvement In Their Health-Related Quality Of Life During The First Year On Treatment: Growth Mixture Modeling Of a Prospective Cohort Of Newly Diagnosed Patients

Bin Huang1, Chen Chen2, Stacey Niehaus3, Hermine Brunner4, Rina Mina5 and Michael Seid6, 1Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center/University of Cincinnati School of Medicine, Cincinnati, OH, 2Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Cincinnati Children's Hospital Medical Center/University of Cincinnati School of Medicine, Cincinnati, OH, 5Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Pulmonary, Cincinnati Children's Hospital Medical Center/University of Cincinnati School of Medicine, Cincinnati, OH

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA), longitudinal studies, quality of life and statistical methods

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects I: Juvenile Idiopathic Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Health-related quality of life (HRQOL) is a key outcome in clinical care and research for children with JIA.  Despite excellent clinical control and the availability of biologic treatment, HRQOL remains suboptimal in half of patients with JIA.  The aims of the study were, for children with JIA during the first year post diagnosis with JIA, to:  1) identify distinct patterns of improvement in HRQOL; and 2) identify baseline disease, patient/parental characteristics that predict improvement in HRQOL.

Methods: Patients were enrolled within 6 months of diagnosis (N=230; 2-16 years of age), and followed up semi-annually.  Patient HRQOL (Generic and Rheumatologic Core via self-report if ≥5 years and parental proxy-report) and non-medical patient/parental characteristics were obtained via survey during clinic visits; disease medical characteristics were obtained from clinical database. Primary outcome Generic PedsQL total score has mean 83 in healthy children, with <78.6 considered suboptimal. Longitudinal growth mixture model (GMM) was used to identify patterns (latent class) of improvement in HRQOL.  Multivariable multinomial logistic regression with stepwise selection was used to predict GMM latent class membership using baseline measures; the model predictive ability was evaluated by the receiver operation characteristics (ROC, 1.0 being perfect).

Results: Table 1 presents study results for primary study outcome. Three distinct patterns of improvement were identified for patient self-report: 72% of patients maintained HRQOL at healthy norm (class I:  84.46+0.23×month), 21% improved (class III: 54.46+2.03×month), but 13% of patients with initial suboptimal HRQOL deteriorated over time (class II: 66.63-1.40×month).  Modeling parent proxy-report, four latent classes were identified.  The final logistic regression model for patient self-report found that less pain, adherence barriers, better self-efficacy managing emotion, and social support from parents are most predictive to more favorite pattern of HRQOL improvement (ROC 0.90). The final model for parental proxy-report found that parent- reports of less child pain and adherence barriers, better functional status and lower parental distress at baseline predicts more favorite pattern of improvement in child HRQOL (ROC 0.83).

Conclusion: During the first year on treatment, children newly diagnosed with JIA showed distinct patterns of improvement in HRQOL.  Although a majority of JIA patients maintained or reached healthy norm, 28-43% of patients remained or deteriorated below healthy norm, despite therapy, suggesting at risk factors of poor HRQOL outcomes need to be better considered in the care of children with JIA.

 

Table 1. Latent Class of Pattern of Improvement (GMM Results) and their predictors (multinomial logistic regression results)

 

 

HRQOL Self-Report (N = 180)

HRQOL Proxy-Report (N = 230)

Beta (SD) from GMM

 

Class I

(High)

Class II

(Deteriorate)

Class III

(Low Improve)

Class I

(High)

Class II

(Stable Suboptimal)

Class III

(Stable poor)

Class IV

(Poor Improve)

 

Number Pts (%)

132

 (72%)

13

(7%)

39

(21%)         

 

129

(57%)

65

(29%)

24

(11%)

10

(4%)

 

Intercept

84.46***

(1.27)

66.63***

(4.08)

54.46***

 (2.24)

88.22***

(1.08)

73.57***

 (2.03)

53.21***

(3.73)

47.11***

(8.32)

 

Slop

0.23

(0.13)

-1.40*

 (0.58)

2.03***

(0.31)

0.54***

(0.10)

0.05

(0.16)

-0.15

(0.43)

4.02***

(0.75)

OR (CI) from Multinomial Logistic Regression

 

Age (year)

Ref

0.87

(0.41,1.84)

1.42

(0.84, 2.41)

Ref

1.01

 (0.70, 1.46)

1.14

(0.64, 2.03)

1.65

(0.75, 3.63)

 

Gender (Female)

 

8.71

 (1.00,76.15)

2.12

(0.58, 7.83)

 

0.57

 (0.27, 1.19)

0.28

(0.08, 1.05)

0.73

(0.08, 6.54)

 

Age at onset (year)

 

1.14

(0.56,2.33)

0.82

(0.50, 1.35)

 

1.01

 (0.70, 1.47)

0.99

(0.54, 1.80)

0.57

(0.25, 1.30)

 

JIA Subtype:

    Oligo vs. Poly

 

1.61

(0.21,12.17)

0.21

(0.03, 1.45)

 

0.47

 (0.19, 1.12)

1.21

 (0.24, 6.15)

0.05

(0.00, 3.23)

 

JIA Subtype:

Other vs. Poly

 

1.27

(0.21,7.76)

1.19

(0.33, 4.27)

 

1.49

 (0.65, 3.41)

0.45

(0.10, 2.15)

0.48

(0.05, 4.21)

 

Less Pain

(PedsQL Rheu. Core)

 

0.96

(0.93,1.00)

0.95***

(0.92, 0.98)

 

0.98**

 (0.96, 0.99)

0.94***

(0.91, 0.97)

0.87***

(0.81, 0.94)

 

Less Adherence Barriers

(PedsQL Rheu. Core)

 

0.93**

(0.89, 0.97)

0.93***

(0.90, 0.97)

 

 

 

 

 

Childhood Health Assessment Questionnaire

(CHAQ)

 

 

 

 

1.52

 (0.81,2.84)

7.62***

(3.06, 19.01)

0.50

(0.10, 2.59)

 

Better Self-Efficacy Emotion

(CASE)

 

0.44*

(0.22, 0.90)

0.54*

(0.33,0.88)

 

 

 

 

 

Better Parental Social Support

(SSC)

 

0.29

(0.05, 1.81)

0.13**

(0.03,0.50)

 

 

 

 

 

More Parental Distress

(SCL)

 

 

 

 

3.96**

 (1.56,10.04)

5.67**

(1.57, 20.46)

12.68***

(2.93, 54.93)

* indicates P<.05; ** indicates P<.01; *** indicates P<.001

 


Disclosure:

B. Huang,
None;

C. Chen,
None;

S. Niehaus,
None;

H. Brunner,
None;

R. Mina,
None;

M. Seid,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/children-with-jia-show-distinct-patterns-of-improvement-in-their-health-related-quality-of-life-during-the-first-year-on-treatment-growth-mixture-modeling-of-a-prospective-cohort-of-newly-diagnosed-p/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology